rs11544803

Variant summary

Our verdict is Uncertain significance. The variant received 5 ACMG points: 5P and 0B. PM2PP2PP3PP5

The NM_014402.5(UQCRQ):​c.134C>T​(p.Ser45Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000656 in 152,390 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)

Consequence

UQCRQ
NM_014402.5 missense

Scores

1
11
6

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 0.398

Publications

13 publications found
Variant links:
Genes affected
UQCRQ (HGNC:29594): (ubiquinol-cytochrome c reductase complex III subunit VII) This gene encodes a ubiquinone-binding protein of low molecular mass. This protein is a small core-associated protein and a subunit of ubiquinol-cytochrome c reductase complex III, which is part of the mitochondrial respiratory chain. [provided by RefSeq, Jul 2008]
GDF9 (HGNC:4224): (growth differentiation factor 9) This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates ovarian function. Reduced expression of this gene may be associated with polycystic ovary syndrome and mutations in this gene may be more common in mothers of dizygotic twins. [provided by RefSeq, Jul 2016]
GDF9 Gene-Disease associations (from GenCC):
  • premature ovarian failure 14
    Inheritance: AD, AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 5 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 1 curated pathogenic missense variants (we use a threshold of 10). The gene has 0 curated benign missense variants. Gene score misZ: 0.41637 (below the threshold of 3.09). Trascript score misZ: 0.23795 (below the threshold of 3.09). GenCC associations: The gene is linked to mitochondrial complex III deficiency nuclear type 4, mitochondrial complex III deficiency, Leigh syndrome.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.776
PP5
Variant 5-132867015-C-T is Pathogenic according to our data. Variant chr5-132867015-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 729.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
UQCRQNM_014402.5 linkc.134C>T p.Ser45Phe missense_variant Exon 2 of 3 ENST00000378670.8 NP_055217.2 O14949

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
UQCRQENST00000378670.8 linkc.134C>T p.Ser45Phe missense_variant Exon 2 of 3 1 NM_014402.5 ENSP00000367939.3 O14949

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152272
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000398
AC:
1
AN:
251036
AF XY:
0.00000736
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
Cov.:
31
GnomAD4 genome
AF:
0.00000656
AC:
1
AN:
152390
Hom.:
0
Cov.:
33
AF XY:
0.00
AC XY:
0
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41596
American (AMR)
AF:
0.00
AC:
0
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68040
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000204
Hom.:
0
Bravo
AF:
0.00000378
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Mitochondrial complex III deficiency nuclear type 4 Pathogenic:2
Jan 05, 2025
First Genomix Gene Laboratory, Genetic Diagnostics Department
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

As part of Carrier Screening testing performed at First Genomix, this variant was identified in a heterozygous state in a patient who is not affected with this condition. -

May 01, 2008
OMIM
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:literature only

- -

not provided Pathogenic:1
Jun 16, 2015
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The S45F variant in the UQCRQ gene has been reported previously in the homozygous state inassociation with mitochondrial complex III deficiency (Barel et al., 2008). The S45F substitution was notobserved at any significant frequency in approximately 6,500 individuals of European and AfricanAmerican ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variantin these populations. The S45F variant is a non-conservative amino acid substitution that is not conservedacross species. In silico analysis predicts this variant is probably damaging to the proteinstructure/function. We interpret S45F as a pathogenic variant. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Uncertain
0.039
T
BayesDel_noAF
Uncertain
0.0
CADD
Benign
20
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.76
D;D;D
Eigen
Benign
-0.25
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.56
D
LIST_S2
Benign
0.75
.;.;T
M_CAP
Uncertain
0.25
D
MetaRNN
Pathogenic
0.78
D;D;D
MetaSVM
Uncertain
0.13
D
PhyloP100
0.40
PrimateAI
Benign
0.29
T
PROVEAN
Uncertain
-4.1
D;D;D
REVEL
Uncertain
0.52
Sift
Uncertain
0.011
D;D;D
Sift4G
Uncertain
0.026
D;D;D
Polyphen
0.96
D;D;D
Vest4
0.36
MVP
0.81
MPC
1.5
ClinPred
0.85
D
GERP RS
2.2
PromoterAI
-0.031
Neutral
Varity_R
0.44
gMVP
0.88
Mutation Taster
=9/91
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11544803; hg19: chr5-132202707; API